OptimizeRx Secures $35 Million Credit Facility to Fuel Growth
OptimizeRx has secured a $35 million credit facility with Fifth Third Bank, providing capital for strategic initiatives and operational flexibility.
OptimizeRx Corp. (NASDAQ: OPRX), a provider of healthcare technology solutions for life sciences companies, announced it has entered into a $35 million senior secured credit facility with Fifth Third Bank. The facility comprises a $25 million term loan and a $10 million revolving credit facility, which was undrawn at closing. Roth Capital Partners served as financial advisor on the transaction.
The new credit facility provides OptimizeRx with significant financial flexibility to support its growth initiatives. The company specializes in connecting life science brands with patients and healthcare providers through its AI-driven platform, which includes the Dynamic Audience Activation Platform (DAAP) and Micro-Neighborhood Targeting (MNT). These tools enable hyper-local, timely engagement that bridges healthcare provider and direct-to-consumer strategies, aiming to accelerate treatment decisions and improve patient outcomes.
This financing comes at a time when the healthcare technology sector is seeing increased demand for digital solutions that enhance patient engagement and streamline marketing efforts. OptimizeRx's platform is designed to deliver privacy-safe, patient-centric interactions, ensuring that life-changing therapies reach the right patients at the right time. The company partners with leading pharmaceutical and life sciences companies to transform the healthcare landscape.
The $35 million facility will likely be used to fund ongoing operations, potential acquisitions, or other strategic initiatives. For more details, the full announcement is available at https://ibn.fm/G0Fj3.
OptimizeRx is headquartered in Waltham, Massachusetts, and is committed to leveraging innovative technology to create a healthier future. The company's focus on AI-driven tools and hyper-local targeting differentiates it in the competitive healthcare marketing space. With the new credit facility, OptimizeRx is well-positioned to capitalize on market opportunities and continue its growth trajectory.
The involvement of Fifth Third Bank underscores the confidence in OptimizeRx's business model and growth prospects. Roth Capital Partners' role as financial advisor also highlights the strategic importance of the transaction. As the healthcare industry increasingly adopts digital solutions, OptimizeRx stands to benefit from its advanced platform and strong financial backing.
For more information about OptimizeRx, visit https://www.optimizerx.com.